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Transcriptionexperimental search for enhancers and silencers in a 153-kb region containing
the human apolipoprotein (APO) E/C1/C4/C2 gene cluster using shotgun cloning into a luciferase vector. A
continuum of transcriptional effect sizes was observed, possibly explaining the limited success of
bioinformatics in identifying regulatory regions. We identiﬁed nine statistically signiﬁcant enhancers and
ﬁve silencers functional in either liver or astrocyte cells, including two previously known enhancers. Only
two of the fourteen elements contained conserved noncoding sequences. Within the coding sequence of the
APOE gene we identiﬁed an enhancer for the E4 allele associated with Alzheimer's disease, but not E3. The
single nucleotide polymorphism (SNP) causing the E4/E3 amino acid substitution was responsible for these
variations, potentially explaining the higher expression levels of E4. Our results suggest a wider variety of
mammalian transcriptional regulatory sequences than is currently recognized and that these may include
coding region SNPs.
© 2008 Elsevier Inc. All rights reserved.Anessential task in deciphering the humangenome sequencewill be
to compile a qdictionaryq of sequences responsible for regulating gene
expression [1]. Furthermore, disruption of normal regulation has been
linked to a number of diseases including hemophilia, anemia, epilepsy,
and a variety of cancers [2]. However, our knowledge of transcriptional
regulatory elements is scarce. Enhancers and silencers can reside far
from the core promoterof a gene andbe either upstreamordownstream
or in intergenic or intronic regions [3]. Known regulatory sequences are
often enriched in transcription factor binding sites, for activators in the
case of enhancers or repressors in the case of silencers [4,5]. Enhancers
and silencers are usually orientation-independent.
Bioinformatic approaches have had limited success in identifying
regulatory elements, with many false predictions. These algorithms
frequently assume that regulatory sequences are likely to be
conserved in evolution [6,7]. Complicating this approach is the fact
that regulatory sequences are often short and highly degenerate.Medical Pharmacology, David
, University of California, Los
).
ity of California, San Francisco,
rinceton University, Princeton,
l rights reserved.Nevertheless, one recent study directly assayed highly conserved
noncoding sequences in transgenic mice and showed enrichment in
tissue-speciﬁc regulatory sequences [8].
Recently, the notion that all regulatory sequences are evolutiona-
rily conserved has been challenged by a study from the ENCODE
consortium [9]. This large project examined 1% of the human genome
for functional elements, using a number of approaches including
transcription factor binding, detailed transcription start site mapping,
and identiﬁcation of DNase I hypersensitive sites. Up to 50% of the
identiﬁed functional elements were nonconserved, a phenomenon
possibly endowing the genome with an evolutionary “stockpile” of
reserve elements.
Direct high-throughput analysis of transcriptional regulatory
elements by transfecting luciferase reporter genes into mammalian
cells has also been employed [10]. The promoters of 613 genes were
examined, consisting of 1,000bp upstream of the transcriptional start
site. Interestingly, there was a signiﬁcant relationship between the
activity proﬁle of the isolated promoters in various tissue culture lines
and the endogenous gene expression proﬁles.
Here we evaluate in a relatively unbiased fashion the transcrip-
tional properties of a 153kb region of human chromosome 19. We
shotgun cloned a BAC harboring the APOE/C1/C4/C2 gene cluster into a
luciferase vector and quantitatively evaluated the resulting fragments
for regulatory activity in liver and astrocyte cells. Overall, our data
293H.P. Chen et al. / Genomics 92 (2008) 292–300indicated that traditional principles guiding the discovery of regula-
tory elements by sequence comparison are too constrained, encoura-
ging the use of more inclusive discovery strategies.
Results
Shotgun cloning, transfection, and luciferase assays
A 153-kb BAC from human chromosome 19 was selected for
analysis. The BAC contains seven known genes: PVRL2, TOMM40,
APOE, APOC1, APOC4, APOC2, and CLPTM1. The APOE/C1/C4/C2 gene
cluster and the APOE gene had previously been analyzed for enhancer
activity by deletion mapping. Two liver enhancers, HCR1 [11] and
HCR2 [12], associated with the APOE/C1/C4/C2 gene cluster were
identiﬁed, as well as two astrocyte enhancers, ME1 and ME2 [13],
associated with the APOE gene. Another enhancer linked with the
APOE gene, BCR, is active in neurons and microglia, but not the cells
tested here, liver and astroglia [14].
The BAC was digested independently by AluI or Sau3AI and
subcloned into the multiple cloning site of the pGL3-promoter vector.
This vector contains the basal SV40 early promoter upstream of the
ﬁreﬂy luciferase gene. Fragments cloned into the multiple cloning site
upstream of the SV40 promoter can act as enhancers to increase ﬁreﬂy
luciferase transcription. A total of 1,798 clones were obtained, 1,049
from AluI and 749 from Sau3AI, with an average size of ∼230bp. The
coverage of the BAC was 1.2-fold for AluI and 1.4-fold for Sau3AI,
giving a total coverage of 2.6-fold.
All members of the pGL3 shotgun library were individually
lipofected into the human liver cell line C3A in a 96-well plate format.
Nearly the entire library (N99%) was also transfected into the human
astrocyte glial cell line SVGP12. All clones were co transfected with
phRL-TK, which contains the Renilla luciferase gene driven by the
ubiquitously expressed HSV-TK promoter. The ﬁreﬂy and Renilla
luciferases employ different substrates and can be assayed indepen-
dently. The Renilla luciferase acts as an internal control for transfection
efﬁciency and results are expressed as the log2 ratio of ﬁreﬂy to Renilla
luciferase activities. As judged using a CMV-GFP construct (pEGFP-N3,
Clontech), the transfection efﬁciency in the 96-well plate format was
uniform at ∼7% for the C3A liver cells and ∼25% for the SVGP12 glial
cells.
Mammalian DNA sequences show a continuum of transcriptional
regulatory properties
The BeadArray package in R was used to quantile normalize the
relative luciferase activities across the experimental plates in the C3A
(Fig. 1A) and SVGP12 (Fig. 1B) cell lines. The control pGL3-basic vector
with no promoter or enhancer had low activity, as expected. The
pGL3-promoter vector containing an SV40 promoter but no enhancer
was found to have a medium amount of luciferase activity. A vector
containing both the promoter and the known enhancer element HCR1
had very high activity.
The distribution of raw relative activity measures for all fragments
in liver C3A cells appeared nearly normal, with a negative tail
potentially representing silencers (Figs. 1C and 1D). To evaluate
whether the apparent normality of the distribution was solely
attributable to experimental noise or whether clone identity made
an appreciable contribution, we modeled the relative luciferase
activity measure under a linear mixed effects model. We treated the
baseline activity as a ﬁxed effect and the fragment effect as random.
We chose 20 clones using a random number generator and assayed
their luciferase activity in liver cells, using 10 replicates for each clone.
One clone was subsequently found to be E. coli DNA and its results
excluded. The model was thus ﬁt to activity data from 19 clones.
A likelihood ratio test revealed that the model including a clone
effect better ﬁtted the data than one in which all variability wastreated as noise (pb0.001). The clone effect accounted for approxi-
mately 40% of the variance, with experimental noise contributing the
balance. Thus the clone effect was substantial, although noise
contributed most to shaping the distribution of luciferase activities.
Fig. 1E shows that the distribution of the estimated activity means of
the 19 random fragments follows closely the distribution of single
measures of activity of all fragments (Fig. 1D), reinforcing the idea that
fragment effects make a signiﬁcant contribution to the variance.
The observation of an apparently continuous effect size raised the
possibility that there may be no categorical distinction between
nonregulatory and regulatory sequences, particularly enhancers. We
explored this issue using Gaussian mixture modeling of 10,000
bootstrap samples of the raw relative activity measures of all
fragments in liver (Fig. 1C). The distributionwas most likely composed
of two modes (p=0.957), corresponding to silencers and nonsilencers.
This is consistentwith the negative tail of the bulk distribution (Fig.1D)
and implies difﬁculty in separating enhancers from nonregulatory
sequences. Three modes consisting of silencer, nonregulatory, and
enhancer sequences had p=0.043, while a unimodal distribution was
not observed; i.e., pb0.0001.
We used mixture modeling to investigate the role of experimental
noise and sample size in the low power to detect an enhancer mode.
Separate enhancer and nonenhancer populations were modeled by
two-component data simulated using empirically derived estimates of
the means and variances from multiple replication experiments (Fig.
1F and below). Experimental variance was modeled either by adding
noise corresponding to our experiments—60% of the overall variance—
or by neglecting it. We also used either our actual sample sizes or
simulated samples tenfold larger.
Noise at a level found in our data completely obscured any
distinction between enhancers and nonenhancers, regardless of
sample size. Even without noise, the two components could not be
separated most of the time at empirical sample sizes, unless
enhancers were on average at least as strong as the HCR1 control.
Increasing the sample size tenfold resulted in reliable multimodal
detection, but curiously resulted in three components on most trials.
Thus, even with much larger sample sizes and no experimental
noise, it appears difﬁcult to separate enhancers and nonregulatory
sequences, while silencers seem to be somewhat more easily
distinguished. These observations may help explain the limited
success of bioinformatic strategies in recognizing transcriptional
control regions.
Identifying regulatory elements
Clones whose values exceeded a threshold of two standard
deviations above and below the mean after normalization were
chosen for a second round of screening, in which their activities
were assayed in duplicate. Fig. 1F summarizes the screening
procedure. Clones whose activities were signiﬁcantly different
upon duplicate testing (t test, df 2, pb0.05) from the pGL3-
promoter-only control were end-sequenced and subjected to a
ﬁnal round of screening. Through end-sequencing, we eliminated
all fragments containing either multiple inserts or E. coli DNA, as
judged using BLAST (NCBI) [15]. For the remaining clones, the ﬁnal
screen consisted of 10 replicate assays. Clones were eliminated that
were not signiﬁcantly different from the pGL3-promoter control as
judged using t-tests (df 18, pb0.05) with a Bonferroni correction for
multiple hypothesis testing.
Both conserved and nonconserved sequences constitute
regulatory elements
The genomic locations of the identiﬁed regulatory sequences that
passed the ﬁnal screen are shown in Fig. 2A. Of the fragments active in
liver cells, ﬁvewere intronic, one was exonic, and four were intergenic
Fig.1.Distributions and workﬂow. (A)Quantile normalization of relative luciferase activity for all fragments in liver C3A cells comparedwithin and between plates. Relative luciferase
activity is the log2 ratio of ﬁreﬂy luciferase to Renilla luciferase. Batch number indicates corresponding 96-well plate. (B) Quantile normalization in astroglial SVGP12 cells. (C)
Distribution of raw relative luciferase activities for all fragments tested in liver C3A cells. The distribution appears unimodal and nearly normal. (D) Q–Q normal plot of all fragments
in C3A cells. The majority of points lie within a normal distribution (line). A negative tail is present. (E) Q–Q normal plot of mean activity of 20 randomly chosen fragments. A normal
distribution with a negative tail is replicated. (F) Workﬂow for identifying regulatory elements.
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silencers (Fig. 2B). For the astroglial cells, three fragments were
intergenic and one was intronic (Fig. 2A). Of the glial elements, three
were enhancers and one was a silencer (Fig. 2C).Two liver [11,12] and two astroglial [13] enhancers had previously
been identiﬁed in the BAC. Of these four elements, we recovered two.
The HCR2 liver enhancer associated with the APOE/C1/C4/C2 gene
cluster was recovered in clone H6. The ME2 astroglial enhancer
Fig. 2. Putative regulatory elements. (A) Enhancers and silencers. Expression values for each gene in brain and liver deduced from SymAtlas [38]. (B)Mean activities of 10 replicates of
selected fragments in liver cells. Fold change relative to promoter-only construct shown. Error bars, standard error of the mean. (⁎, pb0.0001 compared to promoter-only construct,
all ﬁgures.) (C) Selected fragments in astroglial cells. (D) Conserved and repetitive sequence within regulatory elements.
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Fig. 3. Regulatory effects of evolutionarily conserved regions and Alu repeat elements. (A) Fragment H2 has two regions of conservation among vertebrates. The 45-bp region is
responsible for enhancer activity. (B) A portion of H1 contains an Alu repeat element. Only full-length H1 in the forward orientation shows silencer activity.
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rediscovery rate suggests that the search for regulatory sequences in
the BAC was reasonably comprehensive, consistent with the 2.6-fold
clone coverage. Each of the enhancers and silencers we identiﬁed
could be closely associated with one of the genes in the BAC. For
example, two liver enhancers and two liver silencers were found
within the CLPTM1 gene.
RepeatMasker [16] and phastCons [17] were employed to ﬁnd
repetitive sequences and conserved regions, respectively, in the
discovered regulatory sequences. The locations of these elements
are shown in Fig. 2D. Of the 14 regulatory elements we identiﬁed, 6
harbored repetitive sequences for greater than 50% of their lengths.
These elements acted as both enhancers and silencers in liver and
astroglial cells. There are precedents for repetitive sequences playing a
role in mammalian gene regulation [18]. For example, Alu elements
have been shown to act as positive and negative regulatory elementsin the γ chain gene of the high-afﬁnity IgE receptor [19]. In another
example, a silencer of the Wilms' tumor 1 gene has been shown to be
dependent on an Alu element for activity [20].
Of the single-copy noncoding DNA present in all 14 regulatory
elements, only 10.9% distributed across three blocks had signiﬁcant
conservation among vertebrates, as judged by phastCons [16]. Two of
the conserved blocks (70bp and 45bp) were found in the liver
enhancer H2 and the third (63bp) was found in the liver enhancer H6.
The low proportion of conserved elements suggests that bioinformatic
approaches relying on sequence conservation have limited power to
detect control elements, consistent with our observation that there
are relatively small effect differences between regulatory and
nonregulatory sequences.
We performed additional experiments to narrow down the
particular sequences responsible for enhancer or silencer activity.
Fragment H2 (396bp), a liver enhancer, contained two regions that are
Fig. 4. Exon 4 coding region of APOE shows differential regulatory activity between E3 and E4 alleles. (A) Region of APOE exon4 in fragment H3. APOE E3 and E4 differ by a one
nucleotide missense mutation. (B) APOE4 allele in the H3 fragment shows orientation-independent enhancer activity in liver C3A cells, (C) astroglial SVGP12 cells, and (D) astroglial
DBTRG cells. The E3 allele shows no enhancer activity in any cell line.
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phastCons conservation LOD scores surpassing a threshold of 20 (Fig.
3A, left). The resected 70-bp conserved region showed relative
luciferase activity comparable to the promoter-only control (Fig. 3A,
right). The resected 45-bp conserved region and the full-length
fragment showed similar luciferase activities that were both sig-
niﬁcantly greater than promoter control (pb0.0001).
Fragment H1 (157bp), a liver silencer, contained a 45-bp single-
copy region and a 112-bp piece of a repetitive Alu element (Fig. 3B,
left). This silencer fragment is in the ﬁrst intron of the PVRL2 gene and
was cloned in the same orientation relative to the SV40 promoter of
pGL3, though upstream rather than downstream. Neither the 112-bp
region nor the 45-bp region of H1 by itself recapitulated the silencer
effect of this element. Only the full H1 fragment in the forward
orientation and not the reverse signiﬁcantly suppressed luciferase
activity compared to the promoter-alone control (Fig. 3B, right),
suggesting that the silencer effect of H1 is an orientation-dependent
property of the entire fragment.
An E3/E4 allele-dependent coding region enhancer in APOE
Fragment H3 (108bp) was contained entirely within the exon 4
coding region of APOE and exhibited enhancer activity in liver cells(Figs. 2A and 2D). The H3 fragment represents the E4 allele of APOE,
the allele on the parental BAC (Fig. 4A). APOE is ubiquitously
transcribed, and the E4 allele is associated with a higher level of
APOE transcripts than the E3 allele in astroglial cells [24]. The E4 allele
is also associated with an increased risk of Alzheimer's disease [21, 22]
and elevated levels of cholesterol [23].
We conﬁrmed that the 108-bp H3 fragment containing the E4
allele was an active enhancer in C3A liver and SVGP12 astroglial cells
(Figs. 4B and 4C). We end sequenced the top 34 clones that just failed
to make the cutoff in the initial screen of clones using the SVGP12
astroglial cell line and found that the H3 clone had positive
transcriptional effects, being 1.22 standard deviations above the
mean. We further conﬁrmed the enhancer activity of H3 in astroglial
cells by transfecting the clone into the additional human cell line
DBTRG (Fig. 4D).
The E4 allele differs from the more common E3 allele by a single
nucleotide missense mutation that changes a cysteine to an arginine
(Fig. 4A). We investigated whether the enhancer activity associated
with exon 4 of APOEmight explain the differing transcript levels of the
E3 and E4 alleles. In contrast to the E4 allele, the 108-bp region of the
E3 allele corresponding to fragment H3 showed no enhancer activity
in any of the cell lines investigated (Figs. 4B–4D). Furthermore, the
108-bp E4 allele coding sequence fragment showed orientation-
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lines (Figs. 4B–4D). This observation indicates that the APOE E4 allele
coding region sequence behaves in an orientation-independent
manner typical of a genuine enhancer.
Orientation-independent enhancer activity
To further investigate orientation independence, liver enhancers
H6 (125bp) and H8 (207bp) were assayed for regulatory activity when
inserted in either the forward or reverse orientations. Both exhibited
orientation-independent enhancer activity (Fig. 5A).
Copy number does not explain regulatory effects
To exclude the possibility that differences in transcript levels were
due to varying plasmid replication levels, we evaluated the copy
number of the luciferase gene compared to the endogenous RNase PFig. 5. Orientation independence and copy number. (A) Fragments H6 and H8 show
orientation-independent activity in liver C3A cells. (B) Relative clone copy number in
transfected liver C3A cells (RNase P/luciferase).gene (Fig. 5B). There was no relation between transfection efﬁciency
and regulatory activity (r=-0.387, df=11, p=0.192).
Discussion
Our relatively unbiased approach to the discovery of gene
regulatory elements efﬁciently uncovered novel elements in inter-
genic, conserved, nonconserved, and coding regions. We used 4-base
cutters to strike a balance between usefully narrowing transcription
regulatory sequences and having too many fragments to assay.
However, 4-base cutters have an average fragment size of only
256 bp and may not fully encompass some functional elements,
abolishing or decreasing their activity. This may explain, for example,
the nonrecovery of HCR1 that harbors an AluI site. Using 5 base cutters
might recover larger functional elements.
Our analysis suggested that regulatory elements may display a
continuum of transcriptional effects. Gaussian mixture modeling also
suggested that enhancers were separated from nonregulatory
sequences by at most only a small effect size, while silencers had
somewhat stronger effects. A clearer view of this proposition would
emerge with experimental methods to evaluate regulatory sequences
with less noise and higher throughput. One potential source of
variation in our study was due to transfection in the 96-well plate
format. Thiswasmitigated by the dual-channel design of the luciferase
assay. In addition, the transfection efﬁciency was uniform, as judged
using GFP, and the regulatory properties of the identiﬁed elements
were not due to variations in copy number based on real-time PCR.
The weak separation of regulatory and nonregulatory sequences
may help explain the limited success of bioinformatics in identifying
such control elements. It may also have evolutionary implications,
shedding light on the observation that both large [25] and small
regulatory effects [26] can occur as a result of minor sequence
changes. However, our work has been done entirely in tissue culture
cells and the results can be quite different, even opposite, in vivo [14].
In addition, elements that are functional in the whole organism but
not in tissue culture will be missed in our screen.
Because of the apparent continuum of transcriptional effect size,
we employed a stringent protocol incorporating thresholding and
additional rounds of multiple replication to identify clones with
consistently strong regulatory activity. Putative regulatory elements
may have failed at any of these steps and are another reason that the
list of elements may be incomplete.
We identiﬁed nine enhancers that passed the screen, six in liver
cells and three in astroglial cells, and ﬁve silencers, four in liver cells
and one in astroglial cells. Each of the seven known genes within the
BAC seemed to be associated with at least one regulatory element,
based on position.
Consistent with a continuum of transcriptional effects, we found
only 2 out of the 14 putative regulatory elements with conserved
noncoding sequences. These results suggest that current approaches
of identifying enhancers based on conserved regions may be too
constrained [8, 27–30]. Recent comprehensive biochemical studies of
1% of the human genome in the ENCODE project have shown that
important functions of DNA such as transcription factor binding can
reside in both conserved and nonconserved regions [9]. It is possible
that there is an evolutionary advantage to having much of the genome
consisting of sequences poised on the brink of being regulatory or
nonregulatory. A small sequence change in the qstockpileq of
nonregulatory elements could then dramatically change the expres-
sion or properties of a relevant target gene.
One enhancer of 396 bp had two conserved elements of 70 and
45 bp. The enhancer properties of this fragment were entirely due to
the 45-bp region. We also analyzed a silencer containing part of a
repetitive Alu element. Only the entire fragment in a forward
orientation showed silencer activity. Our result echoes the previous
discovery of an orientation-dependent silencer consisting of a partial
299H.P. Chen et al. / Genomics 92 (2008) 292–300Alu element in the CD8α gene [31]. A cruciform structure was
implicated in this silencer effect. The transcriptional effects of
repetitive sequence observed in our and other studies contribute to
the growing body of evidence that “junk” DNA plays an important role
in gene regulation [18].
Interestingly, we discovered a novel enhancer element entirely
within the exon 4 coding region of the APOE gene. To our knowledge,
this is the ﬁrst report of an enhancer residing solely within a coding
sequence. The only other description of an enhancer element in an
exonic sequence was in the 3' untranslated region of the GADD45A
gene [32].
The APOE enhancer encompassed the single nucleotide poly-
morphism (SNP) responsible for distinguishing between the E4 and E3
alleles of APOE. The polymorphism causes an amino acid change from
arginine to cysteine in the APOE4 allele compared to APOE3 and is the
only difference between the alleles in the 108 bp of the identiﬁed
enhancer fragment. Only the E4 allele, and not E3, showed enhancer
activity.
The APOE4 allele is a known risk factor for late-onset Alzheimer's
disease [21, 22]. The allele is associated with greater deposition of
amyloid-β peptides in the brain, a hallmark of Alzheimer's disease
[33], and also with hypercholesterolemia [24]. Furthermore, the E4
allele is more highly expressed than E3. The increased expression of E4
may reﬂect an intrinsic effect of the allele [24]. Our results corroborate
this supposition. Thus, the adverse effects of the E4 allele may be
related not only to alterations in protein chemistry but also to changes
in transcriptional activity.
The frequency with which enhancers reside within coding
sequences is unknown. However, if prevalent, evolutionary con-
straints on coding sequence may extend beyond the genetic code to
also encompass transcriptional regulation. A recent precedent was
established by the demonstration that DNA encodes for histone
positioning as well as protein sequence [34]. Bioinformatic
approaches to ﬁnding transcriptional regulatory elements in coding
regions will clearly be challenging, since the genetic code will
dominate any statistical signal. Thus, deeper experimental searches
for such regulatory sequences will be necessary. Our observation that
a SNP causing an amino acid change has transcriptional consequences
suggests that the many identiﬁed coding region SNPs (cSNPs) [35] in
the human genome may have signiﬁcance for their effects on not only
protein function but also transcription.
Unbiased experimental searchmethods such as described herewill
be useful in identifying regulatory elements in other genomic regions.
However, additional analyseswill be necessary to identify theminimal
sequences necessary and sufﬁcient for regulatory function. Recombi-
neering in BACs will be a relatively high-throughput approach for
evaluating potential control sequences in a more natural context [36].
Our ﬁndings underscore the notion that sequence conservation is not
a necessary property of a regulatory sequence. As much of the genome
remains unannotated, it is important to approach the discovery of
transcriptional regulators without a priori assumptions of sequence,
conservation, or location.
Materials and methods
Library construction
A BAC (RP11-1147O10, Children's Hospital Oakland Research
Institute) was selected from the RPCI-11 human male BAC library
[37]. The BAC is located on chromosome 19 and extends 153.407 kb
from 50031316 to 50184722 (NCBI Build 36.1). The BAC was
independently digested with AluI or Sau3AI (New England Biolabs)
and subcloned into the pGL3-promoter vector (Promega) digested
with SmaI or BglII, respectively. Following ligation, TOP 10 chemically
competent bacteria were transformed (Invitrogen), clones isolated,
and plasmid DNA puriﬁed (Qiagen) for screening.Control clones
The pGL3-promoter and pGL3-basic vector were from Promega. As
a positive control in C3A cells, we used the previously identiﬁed
human APOE liver-speciﬁc enhancer HCR1 [11] inserted into the pGL3-
promoter vector. As a positive control in SVGP12 cells, we used the
previously identiﬁed human APOE brain-speciﬁc enhancer ME2 [13]
also inserted into the pGL3-promoter vector.
Transfection and reporter gene activity assays
We co-transfected 100 ng of experimental ﬁreﬂy luciferase
plasmid with 10 ng of Renilla luciferase plasmid (phRL-TK, Promega)
into C3A, SVGP12, and DBTRG-05MG human cells (ATCC) using
Effectene transfection reagent (Qiagen) in 96-well plates. The Renilla
luciferase plasmid acted as an internal control for transfection
efﬁciency. Cells were at 80% conﬂuence at the time of transfection.
We grew C3A and SVGP12 cells in Eagle's Minimum Essential medium
(ATCC 30-2003) and DBTRG-05MG cells in RPMI-1640 medium (ATCC
30-2001). Cells were lysed after 24 h. We assayed luciferase activity
using the Dual-Luciferase Assay Kit (Promega).
Screens and sequencing
Relative luciferase activity was calculated as the log2 ratio of ﬁreﬂy
to Renilla luciferase signal. These raw data were then normalized
using a quantile normalization method (Illumina BeadArray Technol-
ogy). Clones whose activities were two standard deviations away from
the mean after normalization were considered outliers and subjected
to further screening. Sequencing was performed at the UCLA
Genotyping and Sequencing Core. PhastCons, RepeatMasker, and the
UCSC Genome Browser (http://genome.ucsc.edu) were used to search
for conserved regions and repetitive families.
Linear mixed effects modeling
We randomly chose 19 clones from our library and transfected
each clone into C3A cells. The luciferase activity of each clone was
assayed 10 times to estimate both within-clone and between-clone
effects. The resulting data was then ﬁt by a linear mixed effect model
y=β + bi +ɛ, where y is the relative luciferase activity, β is the ﬁxed
baseline effect, bi is the random between-clone effect, and ɛ is within-
clone noise. As a check for the ﬁt of the model, we performed a
likelihood ratio test comparing the likelihood of the model including a
between-clone effect to the likelihood of a model with no clone effect
(y=β+ɛ). To estimate the proportion of variance accounted for by
between-clone effects, we calculated the ratio of variance of the clone
effects (σbi2 =0.334) to the total variance (σbi2 +σɛ2=0.823). To check the
distribution of the randomly chosen 19 clones, we ﬁt each clone's set
of activities to a linear regression model and found that the intercepts
for each regression followed a distribution similar to the distribution
of all clones tested in C3A cells.
Gaussian mixture modeling
The distribution of log2 raw relative activity measures for all
fragments in liver C3A cells was subjected to bootstrap resampling
10,000 times. Each sample was modeled as a mixture of one to nine
Gaussian components, and the optimal number of component distribu-
tions characterizing the full distribution evaluated. In 9,570 samples, the
best model contained two components (μ1=-2.809±2.124, μ2=3.947±
0.044). In the other 430 samples, the best model contained three
components (μ1=-3.937±1.751, μ2=3.828±0.231, μ3=4.132±0.414).
To estimate our power to identify distinct enhancer and none-
nhancer distributions, we performed mixture modeling on simulated
data in which samples sizes and noise were varied. Two normal
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mean of 3.82, estimated by the mean regulatory activity of the pGL3-
promoter control, and the second with one of seven means between
4.74 and 6.64, estimated by the mean regulatory activities of the six
discovered liver enhancers and the HCR1 enhancer control. The
variances attributable to between-fragment effects were assumed
equal and estimated by the variance of the means of the seven liver
enhancers (f2-σ2=0.520).
For each pair of distributions generated, 1,000 samples were taken.
Each bootstrap sample consisted of 1,731 values, 1,724 from the
nonregulatory distribution and 7 from the enhancer distribution,
reﬂecting experimental sample sizes. To explore improved sample size,
the bootstrap sample was also increased to 10 times the experimental
numbers. In addition, experimental noise composing 60% of the overall
variancewas either added or omitted. The optimal number of Gaussian
mixture componentswas then calculated for each sample distribution.
For noiseless data with empirical sample sizes, single-component
models were best (p=0.831 to 1) with one exception, corresponding to
the largest mean difference tested, 2.82, for which a single-component
model was optimal for 49.2% of the samples. Noiseless distributions at
tenfold larger sample sizes were modeled most often with a single
component up to a mean difference of 2.03 (p=0.81 to 1). Distribu-
tions with larger mean differences were generally modeled by three
components (p=0.46 to 0.97). Adding noise almost always resulted in
models with a single component (p=0.99 to 1), regardless of sample
sizes.
Quantitative real-time PCR for copy number analysis
For each clone, 400 ng DNA was transfected into C3A cells. DNA
was isolated using DNeasy tissue kits (Qiagen) after 24 h. Each sample
set included human liver cell genomic DNA and individual pGL3-insert
DNA as controls. Twenty ng of each sample of DNA was employed for
the real-time PCR assay. We also measured the RNase P gene as an
endogenous control in each sample to normalize for any variation in
absolute quantities.
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